Skip to content

Emergent Biosolutions EBS Accrued Income Taxes, Current

Accrued Income Taxes, Current at other companies

AMP
Amphastar PharmaceuticalsAMPH
$414K-97.3%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$7.8M
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$26M+117%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Medline, Inc.
 logo
Medline, Inc. MDLN
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's accrued income taxes, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's accrued income taxes, current?
Emergent Biosolutions (EBS) reported accrued income taxes, current of $7.2M in Q1 2026.
What does accrued income taxes, current mean?
This represents the estimated amount of income tax payable to government authorities for the current period. It reflects the company's tax liability based on taxable income generated during the year, which is due within the next twelve months. It is a key indicator of the company's immediate tax obligations.